Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Reduce the rate of acute hepatitis B — IID‑11

Status: Improving

  
Improving
Learn more about our data release schedule

Most Recent Data:
0.6 cases of acute hepatitis B per 100,000 population (2021)

Target:
0.1 per 100,000

Desired Direction:
Decrease desired

Baseline:
1.1 cases of acute hepatitis B per 100,000 population were reported in 2017

See detailed data for this objective

Reduce the rate of acute hepatitis B

Target-Setting Method
Maintain consistency with national programs, regulations, policies, or laws

Data Sources:  National Notifiable Diseases Surveillance System (NNDSS), CDC/CSELS; Bridged-race Population Estimates, CDC/NCHS and Census

Learn more about data measurement for this objective

Summary

Thousands of people get acute hepatitis B in the United States every year. While the infection can go away, some people develop a lifelong infection and are at increased risk for liver disease, cirrhosis, and liver cancer. Making sure all infants, children, and at-risk adults get the hepatitis B vaccine can help reduce the rate of acute hepatitis B nationwide.

Topics:  Infectious Disease, Sexually Transmitted Infections, Vaccination

Workgroup: Immunization and Infectious Diseases Workgroup

Other objectives you may be interested in

Browse all Healthy People 2030 objectives